Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes.
İffet Merve Uçar BaytaroğluHatice DaldalMerve Uçar TorosHatice DaldalPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2024)
TNF inhibitors, with their anti-inflammatory effects, positively impact diabetic complications by reducing the incidence of retinopathy. To our knowledge, this is the first study to evaluate retinopathy development after anti-TNF therapy.